Top Wall Street analysts have made some notable changes to their outlook on certain stocks. For a comprehensive overview of all analyst rating changes, including upgrades and downgrades, please refer to our analyst ratings page.
Morgan Stanley has raised the price target for Regency Centers Corporation (NASDAQ:REG) from $62 to $75. Analyst Ronald Kamdem upgraded the stock from Equal-Weight to Overweight. Despite this positive news, Regency Centers shares experienced a slight decline of 1.3%, closing at $65.54 on Wednesday. To get a broader perspective on this stock, take a look at how other analysts view it.
Wedbush has increased the price target for Amazon.com, Inc. (NASDAQ:AMZN) from $180 to $210. Analyst Scott Devitt has maintained an Outperform rating on the stock. However, Amazon shares saw a 1.1% decrease, closing at $152.12 on Wednesday. To gain further insights into this stock, explore how other analysts view it.
Wells Fargo has lowered the price target for argenx SE (NASDAQ:ARGX) from $585 to $470. Analyst Derek Archila has maintained an Overweight rating on the stock. Unfortunately, argenx shares suffered a significant decline of 25.1%, closing at $338.91 on Wednesday. To understand different perspectives on this stock, see how other analysts view it.
Deutsche Bank has increased the price target for Micron Technology, Inc. (NASDAQ:MU) from $85 to $90. Analyst Sidney Ho has maintained a Buy rating on the stock. Despite this positive adjustment, Micron shares experienced a 4.2% decrease, closing at $78.69 on Wednesday. To gain a comprehensive understanding of this stock, explore how other analysts view it.
HC Wainwright & Co. has raised the price target for Immunovant, Inc. (NASDAQ:IMVT) from $47 to $51. Analyst Douglas Tsao has maintained a Buy rating on the stock. However, Immunovant shares saw a decline of 12.8%, closing at $36.18 on Wednesday. To see different perspectives on this stock, check out how other analysts view it.
Needham has increased the price target for CrowdStrike Holdings, Inc. (NASDAQ:CRWD) from $250 to $325. Analyst Alex Henderson has maintained a Buy rating on the stock. Despite this positive adjustment, CrowdStrike shares experienced a 1.7% decrease, closing at $253.95 on Wednesday. To gain further insights into this stock, explore how other analysts view it.
Morgan Stanley has raised the price target for Salesforce, Inc. (NYSE:CRM) from $290 to $350. Analyst Keith Weiss has upgraded the stock from Equal-Weight to Overweight. Unfortunately, Salesforce shares saw a decline of 1.6%, closing at $260.25 on Wednesday. To understand different perspectives on this stock, see how other analysts view it.
Pivotal Research has increased the price target for Spotify Technology S.A. (NYSE:SPOT) from $170 to $265. Analyst Jeffrey Wlodarczak has upgraded the stock from Hold to Buy. However, Spotify shares experienced a 1.1% decrease, closing at $188.71 on Wednesday. To gain a comprehensive understanding of this stock, explore how other analysts view it.
Baird has increased the price target for Insulet Corporation (NASDAQ:PODD) from $180 to $238. Analyst Jeff Johnson has upgraded the stock from Neutral to Outperform. Despite this positive news, Insulet shares saw a decline of 3.1%, closing at $207.97 on Wednesday. To see different perspectives on this stock, check out how other analysts view it.
JP Morgan has raised the price target for Glaukos Corporation (NYSE:GKOS) from $66 to $91. Analyst Allen Gong has upgraded the stock from Neutral to Overweight. Unfortunately, Glaukos shares experienced a 2% decrease, closing at $79.60 on Wednesday. To gain further insights into this stock, explore how other analysts view it.
Remember to check out our article on Micron, Carnival, and three other stocks to watch heading into Thursday.